英文 中文

A Whole New Game? Innovation and Regulation in China and Switzerland

Switzerland is home to a highly innovative life sciences cluster. Many multinational corporations, as well as a network of smaller companies and startups have operations in Switzerland, mostly in the Basel Area. The industry is vibrant, with many innovative developments occurring in pharmaceuticals, biotech or digital health.

In China, the life sciences industry has been growing at an accelerated pace in the last few years and at the same time China is moving towards becoming the largest pharmaceutical market in the world. Both, Swiss and Chinese companies have a lot to gain from innovation and international expansion.

During this year's Swiss-Chinese Life Sciences Forum, we will address current key issues in the industry. Guest speakers from Swiss as well as Chinese companies will present insights into the following topics:


·       Ways to set up operations in Switzerland to access the European market

·       Innovation at startups

·       Macro-economic trends in the life sciences industry and regulatory developments

·       Strengthening Sino-Swiss collaboration


We are looking forward to welcoming you at this year's Life Sciences Forum!


Please click HERE for registration until March 15, 2022. You will be redirected to our cooperation partner Basel Area.


This event is organized by the Swiss-Chinese Chamber of Commerce, in cooperation with Basel Area and VISCHER.











This event is kindly supported by Swisscham China and HKTDC.




Programm Details

09:30
Welcome Remarks by the Swiss-Chinese Chamber of Commerce, VISCHER AG and Basel Area Business & Innovation
B. Wei, General Manager, SCCC | C. Wyss, Partner, Vischer | A. Hollnagel, Director Asia, Basel Area
09:35
Introduction of Panelists l
G. Schweizer, Moderator
09:40
Cancer has No Borders! BeiGene’s Way from Beijing to Basel and a Global Organization
N. Eckardt, Vice President Medical Affairs Europe, BeiGene
09:55
From Europe to China and Back – How WORG Pharmaceutical Leverages the Best of Both Worlds
R. Henning, Chief Scientific Officer & Head of European Operations, Worg Pharm Co. Ltd.
10:10
Game Changing Innovation - HK Biorhythm’s Technology and Strategy for Internationalization
J. Liu, CEO, HK Bio Rhythm R&D Company Ltd.
10:25
Panel Discussion l
N. Eckardt | R. Henning | J. Liu
10:40
Coffee Break
10:55
Introduction of Panelists ll
G. Schweizer
11:00
Is the Chinese Biotech Industry Overheated? Macroeconomic Trends in the Life Sciences Industry
P. Jantzer, Senior Managing Director, Accenture
11:15
Entering the Chinese pharmaceutical market – requirements for marketing authorization holders
M. Zhan, Senior RA Consultant, Accestra
11:30
New Ways of Innovating – What China Expects from Chinese Startups
Q. Tang, Head of Roche Accelerator China, Roche
11:45
Panel Discussion ll
P. Jantzer | M. Zhan | Q. Tang
12:00
Closing
B. Wei | C. Wyss | A. Hollnagel
Swiss-Chinese Life Sciences Forum 2022
三月 16, 2022
09:30-12:00
Online
更多。。。
演讲者
Ms. Anke Hollnagel
Director Asia, Basel Area Business & Innovation
Mr. Christian Wyss
Partner, VISCHER AG
Ms. Beilun Wei
General Manager, Swiss-Chinese Chamber of Commerce
Mr. Gabriel Schweizer
Moderator
Mr. Nils Eckardt
Vice President Medical Affairs Europe, BeiGene
Mr. Rainer Henning
Chief Scientific Officer and Head of European Operations, Worg Pharm Co., Ltd.
Ms. Julia Liu
CEO, HK Bio Rhythm R&D Company Ltd.
Ms. Petra Jantzer
Senior Managing Director, Accenture
Ms. Marylène Zhan
Senior RA Consultant, Accestra
Mr. Qiusong Tang
Head of Roche Accelerator China, Roche
附加信息

This event is organized in cooperation with Basel Area Business & Innovation and VISCHER AG. It is kindly supported by Swisscham China and HKTDC.

Please click HERE for registration until March 15, 2022. You will be redirected to our cooperation partner Basel Area.

展览馆